Skip to main content
. Author manuscript; available in PMC: 2011 Apr 13.
Published in final edited form as: Arch Ophthalmol. 2011 Apr;129(4):481–489. doi: 10.1001/archophthalmol.2011.48

Table 4.

Multivariate model odds ratios and 95% confidence intervals for Early Age-Related Macular Degeneration (AMD), assessed from 2001–2004, among participants (<75 years) in quintiles 2–5 compared to one for serum 25-hydroxyvitamin D, assessed in 1993–1998, further adjusted for potential dietary confounders: the Carotenoids and Age-Related Eye Disease Study (n=968)

Quintiles of serum 25(OH)D, nmol/L Serum 25-Hydroxyvitamin D (25(OH)D) P for trend *
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
Median (range) 30 (7, 38) 44 (>38, 50) 56 (>50, 61) 67 (>61, 75) 85 (>75, 165)
Early AMD
# with AMD/# in quintile 42/196 23/190 28/199 24/184 22/199
Multivariate model 1.0 0.50 (0.28–0.87) 0.66 (0.38–1.12) 0.58 (0.33–1.01) 0.52 (0.29–0.91) 0.02
+ lutein and zeaxanthin intake from foods 1.0 0.52 (0.29–0.90) 0.67 (0.39–1.14) 0.59 (0.33–1.03) 0.53 (0.30–0.94) 0.02
+ polyunsaturated fatty acid intake from foods 1.0 0.51 (0.28–0.88) 0.67 (0.39–1.15) 0.61 (0.34–1.06) 0.55 (0.31–0.97) 0.04
+ healthy eating index 2005 1.0 0.53 (0.30–0.93) 0.74 (0.42–1.27) 0.66 (0.36–1.16) 0.57 (0.32–1.01) 0.06
*

A P-value was obtained for the linear trend by replacing the categorical predictor with the continuous variable (serum vitamin D).

Model Worse eye, adjusted for age at photography, month of blood draw, and risk factors for age-related macular degeneration (AMD) (smoking pack years, iris pigmentation, family history of AMD, cardiovascular disease, diabetes, and hormone use status).